Virus specific antibody - based remedies for the urgent prevention and treatment of Ebola virus disease
- Authors: Sizikova TE1, Lebedev VN1, Borisevich SV1
-
Affiliations:
- 48 Central Scientific Research Institute
- Issue: Vol 91, No 11 (2019)
- Pages: 98-104
- Section: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/33717
- DOI: https://doi.org/10.26442/00403660.2019.11.000164
- ID: 33717
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
T E Sizikova
48 Central Scientific Research Instituteк.б.н., н. с. ФГБУ «48 ЦНИИ» МО России, ORCID: 0000-0002-1817-0126 Sergiev Posad, Russia
V N Lebedev
48 Central Scientific Research Instituteд.б.н., проф., в.н.с. ФГБУ «48 ЦНИИ» МО России, ORCID: 0000-0002-6552-4599 Sergiev Posad, Russia
S V Borisevich
48 Central Scientific Research Institute
Email: 48cnii@mil.ru
д.б.н., проф., член-корр. РАН, начальник ФГБУ «48 ЦНИИ» МО России, тел.: 8(496)552-12-06; e-mail: 48cnii@mil.ru; ORCID: 0000-0002-5742-3919 Sergiev Posad, Russia
References
- Эпидемиология, профилактика и лабораторная диагностика болезни, вызванной вирусом Эбола. Практическое руководство. Под ред. Поповой А.Ю., Кутырева В.В. Саратов: Буква, 2015: 244 с.
- Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, Soropogui B, Sow M.S. Emergence of Zaire Ebola Virus Disease in Guinea. New Eng J Med. 2014;378:1418-25. https://doi.org/10.1056/NEJMoa1404505
- Li J, Duan H.J, Chen H.Y, et al. Age and Ebola viral load correlate with mortality and survival time in 288 Ebola virus disease patients. Int J Infect Dis. 2016;42:34-9. https://doi.org/ 10.1016/j.ijid.2015.10.021
- WHO URL: http://apps.who.int/gho/data/node.ebola-sitrep
- Emond R.T, Evans B, Bowen E.T, Lloyd G. A case of Ebola virus infection. Br Med J. 1977;2(6086):541-4. PMID: 890413
- Mupapa K, Massambla M, Ribadi K. Treatment of Ebola virus hemorrhagic fever with.blood transfusions from convalescent patients. J Infect Dis. 1999;179(1):18-23. https://doi.org/10.1086/514298
- Van Griensven J, Edwards T, de Lamballerie X, et al. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. New Eng J Med. 2016;374(1):33-42. https://doi.org/ 10.1056/nejmoa1511812
- Wolf T, Kann G, Becker S, et al. Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care. Lancet. 2015;385(9976):1428-35. https://doi.org/10.1016/S0140-6736(14)62384-9
- Uyeki T.M, Mehta A.K, Davey R.T, et al. Clinical Management of Ebola Virus Disease in the United States and Europe. New Eng J Med. 2016;374(7):636-46. https://doi.org/10.1056/ nejmoa1504874
- Маркин В.А., Михайлов В.В., Краснянский В.П., Борисевич И.В., Фирсова И.В. Разработка принципов экстренной профилактики и лечения лихорадки Эбола. Вопросы вирусологии. 1997;42(1):31-4.
- Dowall S.D, Rayner E, Hall G, Carbonnelle C, Raoul H, Coxon R, Abdulla I.A, Hewson R. Development of a Cost - effective Ovine Polyclonal Antibody-Based Product, EBOTAb, to Treat Ebola Virus Infection. J Infect Dis. 2016;1124-33. https://doi.org/10. 1093/infdis/jiv565
- Jarhling P.B, Geisbert J.B, Swearengen J.R, Larsen T, Geiabert T.W. Ebola hemorrhagic fever: evaluation of passive immunotherapy in nonhuman primates. J Infect Dis. 2007;196(2):400-3. https://doi.org/10.1086/520587
- Dowall S.D, Jacquot F, Landon J, Rayner E, Hall G, Carbonnelle C, Raoul H, Pannetier D, Cameron I, Coxon R, Abdulla I.A, Hewson R, Carroll M.W. Post - exposure treatment of non - human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product. Scientific Reports 7. 2017;4099:1-15. https://doi.org/10.10 38/s41598-017-03910-7
- Донченко В.В., Лебедев В.Н., Маркин В.А., Фирсова И.В. Эффективность вирусспецифических белков в иммуногенезе при экспериментальной лихорадке Марбург. Вопросы вирусологии. 1996;5:216-8.
- Краснянский В.П., Михайлов В.В., Борисевич И.В., Градобоев В.Н., Евсеев А.А., Пшеничнов В.А. Получение гипериммунной лошадиной сыворотки против вируса Эбола. Вопросы вирусологии. 1995;40(3):138-40.
- Борисевич И.В., Михайлов В.В., Краснянский В.П., Градобоев В.Н., Лебединская Е.В., Потрываева Н.В. Разработка и изучение свойств иммуноглобулина против лихорадки Эбола. Вопросы вирусологии. 1995;40(6):270-3.
- Борисевич И.В., Черникова Н.К., Марков В.И., Краснянский В.П., Борисевич С.В., Рождественский Е.В. Опыт применения специфического иммуноглобулина из сыворотки крови лошадей в качестве средства экстренной профилактики лихорадки Эбола. Вопросы вирусологии. 2017;1:25-9. doi: 10.18821/0507-4088-2017-62-1-25-29
- Pyankov O.V, Setoch Y.X, Bodnev S.A, Edmonds J.H, Pyankova O.G, Pyankov S.A, Pali G, Belford S, Lu L, La M, Lovrecz G, Volchkova V.A, Chappell K.J, Waterson D, Marsh G, Young P.B, Agafonov A.A, Farmer J.F, Volchkov V.E, Suhbier A, Khromykh A.A. Successful post - exposure prophylaxis of Ebola infected non - human primates using Ebola glycoprotein - specific equine IgG. Scientific Reports. 2017;7:1-8. https://doi.org/ 10.1038/srep.41537
- WHO Guidelines for the production, control and regulation of snake antivenom immunoglobulins. Avaiable from: http://www.who.int/bloodproducts/snake_antivenoms/snakeantivenomguide/en// Accepted Oct.2016.
- Dye J.M, Wu H, Hooper J.W, Khurana S, Kuehne A.I, Coile E.M, Ortiz R, Fuentes S, Herbert A.S, Golding H, Bakken R.A, Brannan J.M, Kwilas S.A, Sullivan E.J, Luke T.C, Smith G, Glenn G, Li W, Ye L, Yang C, Compans R.W, Tripp R.A, Jiao J.A. Production of potent fully human polyclonal antibodies against Ebola Zaire virus in transchromosomal cattle. Scientific Reports 6. 2016;6:1-9. https://doi.org/10.1038/srep 24897
- Choi W.Y, Hong K.J, Hong J.E, Lee W.J. Progress of vaccine and drug development for Ebola preparedness. Clin Exp Vaccine Res. 2015;4(1):11-6. https://doi. org/10.7774/cevr.2015.4.1.11
- Olinger G.G.Jr, Pettitt J, Kim D, Working C, Bohorov O, Bratcher B, Hiatt E, Hume S.D, Johnson A.K, Morton J, Pauly M, Whaley K.J, Lear C.M, Biggins J.E, Scully C, Hensley L, Zeitlin L. Delayed treatment of Ebola virus infection with plant - derived monoclonal antibodies provides protection in rhesus macaques. Proc Natl Acad Sci USA. 2012;109(44):18030-5. https://doi.org/10.1073/pnas.1213709109
- Qiu X, Audet J, Wong G, Pillet S, Bello A, Cabral T, Strong J.E, Plummer F, Corbett C.R, Alimonti J.B, Kobinger G.P. Successful treatment of ebola virus - infected cynomolgus macaques with monoclonal antibodies. Sci Transl Med. 2012;4(138):1-12. https://doi.org/10.1126/scitranslmed.3003876
- Haque A, Hober D, Blondiaux J. Addressing Therapeutic Options for Ebola Virus Infection in Current and Future Outbreaks. Antimicrob Agents Chemother. 2015;59(10):5892-902. https://doi.org/10.1128/aac.01105-15
- Sayburn A. WHO gives go ahead for experimental treatments to be used in Ebola outbreak. BMJ. 2014;349:1. https://doi.org/10.1136/bmj.g5161
- Zhang Q, Gui M, Niu X, He S, Wang R, Feng Y, Kroeker A, Zuo Y, Wang H, Wang Y, Li J, Li C, Shi Y, Shi X, Gao G, Xiang Y, Qiu X, Chen L, Zhang L. Potent neutralizing monoclonal antibodies against Ebola virus infection. Sci Reports. 2016;6:1-15. https://doi.org/10.1038/srep25856
- Holtsberg F.W, Shulenin S, Vu H, Howell K.A, Patel S.J, Gunn B, Karim M, Lai J.R, Frei J.C, Nyakatura E.K, Zeitlin L, Douglas R, Fusco M.L, Froude J.W, Saphire E.O, Herbert A.S, Wirchnianski A.S, Lear-Rooney C.M, Alter G, Dye J.M, Glass P.J, Warfield K.L, Aman M.J. Pan - ebolavirus and Pan - filovirus Mouse Monoclonal Antibodies: Protection against Ebola and Sudan Viruses. J Virol. 2015;90(1):266-78. https://doi.org/10.1128/jvi.02171-15
- Keck Z.Y, Enterlein S.G, Howell K.A, Vu H, Shulenin S, Warfield K.L, Froude J.W, Araghi N, Douglas R, Biggins J, Lear-Rooney C.M, Wirchnianski A.S, Lau P, Wang Y, Herbert A.S, Dye J.M, Glass P.J, Holtsberg F.W, Foung S.K.H, Aman M.J. Macaque monoclonal antibodies targeting novel conserved epitopes within filovirus glycoprotein. J Virol. 2016;90(1):279-91. https://doi.org/10.1128/jvi.02172-15
- Wec A.Z, Myakatura E.K, Herbert A.S, Howell K.A, Holtsberg F.A, Bakken R.R, Mittler E, Christin J.R, Shulenin S, Jangra R.K, Bharrhan S, Kuehne A.I, Bornholdt Z.A, Flyak A.I, Saphire E.O, Crowe J.E.Jr, Aman M.J, Dye J.M, Lai J.R, Chandran K. A “Trojan horse” bispecific - antibody strategy for broad protection against ebolaviruses. Science. 2016;354(6310):350-4. https://doi.org/10.1126/science.aag 3267